2 completed, 2 unknown, 1 withdrawn. 5 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 2, Unknown 2, Withdrawn 1 |
| Phase 3 | 2 | Completed 1, Withdrawn 1 |
Follow Intestinal Pseudo-Obstruction: new trials by email Literature Review of Intestinal Pseudo-Obstruction trials Research Report on Intestinal Pseudo-Obstruction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Rifaximin for Patients With Chronic Intestinal Pseudo-obstruction: a Phase 2 Trial Rifaximin oral tablet, Placebo oral tablet - Chronic Intestinal Pseudo-obstruction | Phase 2 | Unknown | Yokohama City University | 12 | 2019-12-25 | 2021-06-21 |
| Daikenchuto for Intestinal Dysmotility and Prevention of Postoperative Paralytic Ielus After Pancreaticoduodenectomy Oral/enteral TJ-100 solution, Oral/enteral placebo solution - Paralytic Ileus | Phase 2 | Unknown | Wakayama Medical University | 220 | 2012-08-01 | 2013-12-18 |
| Effects of Gum Chewing on Recovery of Bowel Function Following Abdominal Surgery for Endometrial and Ovarian Cancer Gum chewing - Paralytic Ileus | Phase 2 / Phase 3 | Withdrawn | Chiang Mai University | 2011-07-01 | 2016-08-30 | |
| The Effects of Gum Chewing on Bowel Function Recovery Following Cesarean Section Gum chewing - Paralytic Ileus | Phase 2 / Phase 3 | Completed | Chiang Mai University | 100 | 2010-05-01 | 2011-06-28 |
| Efficacy, Safety, and Tolerability of JNJ-27018966 (Eluxadoline) in the Treatment of Irritable Bowel Syndrome With Diarrhea Eluxadoline, Placebo - Irritable Bowel Syndrome | Phase 2 | Completed | Furiex Pharmaceuticals, Inc | 807 | 2010-04-28 | 2019-10-22 |
Colonic Diseases (1) · Colonic Diseases, Functional (1) · Colonic Pseudo-Obstruction (1) · Diarrhea (1) · Digestive System Diseases (1) · Gastrointestinal Diseases (1) · Intestinal Diseases (1) · Irritable Bowel Syndrome (1) · Scleroderma, Systemic (1) · Signs and Symptoms, Digestive (1)
Ileus (5) · Intestinal Obstruction (5) · Digestive System Diseases (4) · Gastrointestinal Diseases (4) · Intestinal Diseases (4) · Connective Tissue Diseases (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
Chewing Gum (2) · Rifaximin (1) · eluxadoline (1)
Chiang Mai University (2) · Furiex Pharmaceuticals, Inc (1) · Wakayama Medical University (1) · Yokohama City University (1)
Japan (2) · Thailand (2) · United States (1)
Kittipat Charoenkwan, MD (2) · Hiroki Yamaue, M.D., Ph.D. (1)
PMID 23583433, PMID 24813429, PMID 26747224, PMID 28167156, PMID 30333892